Manufacturing | Process Control - World Medical Innovation Forum
WMIF Main Site

Manufacturing | Process Control

Manufacturing | Process Control

Monday, May 2, 2022

2:40 PM – 3:20 PM America Ballroom View Here

Manufacturing quality and cost are critical for enabling rapid growth in GCT. Panelists will explore a variety of critical questions in this space. For example, are there historic parallels that can be drawn between GCT manufacturing and other groundbreaking technologies? How do key manufacturing concerns in GCT differ from those for more conventional pharmaceutical? What are the long-term opportunities for non-viral vectors? Will manufacturing capacity be a limiting factor in GCT growth over the next 5 to 10 years?

John Bishai, PhD
  • Managing Director, Global Investment Banking, BofA Securities
Christopher Murphy
  • Vice President Viral Vector Services, Thermo Fisher
Michael Paglia
  • COO, ElevateBio BaseCamp, ElevateBio
Rahul Singhvi, ScD
  • CEO, National Resilience, Inc.
Ran Zheng
  • CEO, Landmark Bio

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA